Neural Announces Completion of the Acquisition of a 30.75% Interest in Hanf.com, a Profitable German CBD Retail Store Chain
Transaction transforms Neural into company with solid financial fundamentals with significant short, mid and long-term growth prospects Hanf.com achieved sales of €4.9 Million (~CA$7.5M) and a 13% operating profit in 20241. Toronto, Ontario--(Newsfile Corp. - August 13, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-08-13 7:30 AM EDT | Neural Therapeutics Inc.
Quantum BioPharma Announces Update to Previously Announced Private Placement
Toronto, Ontario--(Newsfile Corp. - August 11, 2025) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, announces that further to its press release dated June 27, 2025, the Company will...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-08-11 6:32 PM EDT | Quantum BioPharma Ltd.
Numinus Wellness Inc. Announces First Quarter Fiscal 2025 Results
Vancouver, British Columbia--(Newsfile Corp. - August 8, 2025) - Numinus Wellness Inc. (TSX: NUMI) (OTCQB: NUMIF) (FSE: LR23) ("Numinus" or the "Company"), a mental health care company focused on innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, today announced its financial results for the three months ended November...
2025-08-08 5:00 PM EDT | Numinus Wellness Inc.
PharmaDrug Inc.: Correction to News Release Dated July 30, 2025
Toronto, Ontario--(Newsfile Corp. - July 30, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), announces that the original news release captioned "PharmaDrug Signs LOI to Acquire Equity Interest in Canurta Inc." published on July 30, 2025 referred, incorrectly, to the number of common shares of...
Biotechnology, Cannabis, Psychedelics, Cannabis Manufacturer
2025-07-30 11:37 AM EDT | PharmaDrug Inc.
Red Light Holland CEO Todd Shapiro Invited by Blockchain Futurist Conference for Fireside Chat and Panel Hosting
Toronto, Ontario--(Newsfile Corp. - July 30, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, as well as...
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-07-30 8:05 AM EDT | Red Light Holland Corp.
PharmaDrug Signs LOI to Acquire Equity Interest in Canurta Inc.
Toronto, Ontario--(Newsfile Corp. - July 30, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of natural medicines is announcing that it has entered into a non-binding Letter of Intent ("LOI") on July 23rd, 2025...
Biotechnology, Cannabis, Psychedelics, Cannabis Manufacturer
2025-07-30 7:30 AM EDT | PharmaDrug Inc.
Red Light Holland Reports 2025 Audited Year-End Results - Demonstrates Continued Fiscal Discipline, Strategic Growth, and Psilocybin R&D Expansion
Toronto, Ontario--(Newsfile Corp. - July 29, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms, mushroom home grow kits in North America and Europe, and a premium brand...
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-07-29 7:30 AM EDT | Red Light Holland Corp.
Red Light Holland Provides Timing for 2025 Audited Year-End Results and Announces Live Q&A
Red Light Holland will release its 2025 audited year-end results, prior to the opening of the financial markets on Tuesday, July 29th, 2025CEO Todd Shapiro and CFO Keith Li of Red Light Holland will conduct a live Q&A at 11am on Wednesday, July 30th, 2025.Toronto, Ontario--(Newsfile Corp. - July...
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-07-28 9:19 AM EDT | Red Light Holland Corp.
Numinus Wellness Inc. Announces Fourth Quarter Fiscal 2024 Results
Q4 Fiscal 2024 Highlights1Revenue of $1.2 million, a 16.4% increase over Q3 2024Gross profit of $0.3 million, compared to a loss of $0.05 million in Q3 2024Cash position of $2.0 million as of August 31, 2024Subsequent to Quarter EndOn December 12, 2024, the Company closed on the sale of its...
2025-07-25 6:01 PM EDT | Numinus Wellness Inc.
Red Light Holland Selects Arch Public for Bitcoin Purchases on Recommendation from Advisor Scott Melker
Toronto, Ontario--(Newsfile Corp. - July 25, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, as well as...
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-07-25 8:33 AM EDT | Red Light Holland Corp.
Telescope Innovations Selected to Join ALTA: the First US-Based Lithium Technology Accelerator
Vancouver, British Columbia--(Newsfile Corp. - July 24, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE:4JU) ("Telescope Innovations", "Telescope", or the "Company") is a leader in intelligent automation platforms for accelerating chemical process development. The Company has been hand-picked to join the inaugural cohort of the Arkansas Lithium Technology Accelerator (ALTA),...
Technology, Chemical, Pharmaceuticals, Psychedelics
2025-07-24 8:00 AM EDT | Telescope Innovations Corp.
Neural Announces Approval of the Strategic Investment and Option Agreement by CWE Shareholders to Acquire up to 100% of CWE
Toronto, Ontario--(Newsfile Corp. - July 22, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, and CWE European Holdings Inc. ("CWE"), operating as Hanf.com, one of the Germany's leading...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-07-22 7:30 AM EDT | Neural Therapeutics Inc.
Neural Advances Ethnobotanical Strategy Through Execution of SERFOR Research Agreement and CWE's Exclusive German Distribution Agreement with Ritual Herbs
Toronto, Ontario--(Newsfile Corp. - July 21, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, is pleased to announce two major developments that strengthen its ethnobotanical strategy: (i)...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-07-21 8:53 AM EDT | Neural Therapeutics Inc.
Optimi Health Announces $3.45 Million Convertible Financing and Extension of Secured Term Loan
Vancouver, British Columbia--(Newsfile Corp. - July 18, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Canadian drug manufacturer and formulator of GMP-grade MDMA and natural psilocybin, is pleased to announce that it has entered into subscription agreements pursuant to which it proposes...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-07-18 7:00 AM EDT | Optimi Health Corp.
Telescope Innovations Presents Results of Third Fiscal Quarter 2025
Vancouver, British Columbia--(Newsfile Corp. - July 16, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended May 31, 2025 (Q3). The Company...
Technology, Chemical, Pharmaceuticals, Psychedelics
2025-07-16 3:00 PM EDT | Telescope Innovations Corp.
Red Light Holland Announces Bitcoin Balance Sheet Strategy and Names Scott Melker as Lead Cryptocurrency Advisor
Toronto, Ontario--(Newsfile Corp. - July 15, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, as well as...
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-07-15 8:03 AM EDT | Red Light Holland Corp.
Red Light Holland's FDA-Compliant, DEA-Registered Partner Irvine Labs Receives First Global Shipment of Psilocybin from Company's Netherlands Facility via USA Controlled Substances Permit
Groundbreaking and major precedent setting milestone as first global shipment, via USA Controlled Substances import permit, of naturally occurring Psilocybin from Red Light Holland's facility in Europe successfully delivered to the Company's Partner FDA-Compliant and DEA-Registered Irvine Labs in CaliforniaPsilocybin potency testing and implementation of advanced shelf life extension protocols...
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-07-14 7:45 AM EDT | Red Light Holland Corp.
Steep Hill Terminates SPA with Lir Life Sciences Inc.
Toronto, Ontario--(Newsfile Corp. - July 3, 2025) - Steep Hill Inc. (CSE: STPH) ("Steep Hill" or the "Company") announces that further to its press release of February 12, 2025, the Company has terminated: the (i) share purchase agreement (the "Original Purchase Agreement"), dated as of February 12, 2025, (ii) first amending...
Retail, Cannabis, Psychedelics, Cannabis Manufacturer
2025-07-03 5:00 PM EDT | Steep Hill Inc.
Red Light Holland Announces Dr. Robin Carhart-Harris as Scientific Advisor
Toronto, Ontario--(Newsfile Corp. - July 2, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), a company engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe and a premium brand...
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-07-02 8:12 AM EDT | Red Light Holland Corp.
HealingMaps and Advanced Behavioral Strategies Launch Healing Health Alliance, the First Group Purchasing Organization (GPO) Exclusively for Ketamine, Psychedelic Medicine and TMS Clinics
Miami, Florida--(Newsfile Corp. - July 1, 2025) - HealingMaps, the leading directory for ketamine, psychedelic-assisted therapy, and TMS clinics, and Advanced Behavioral Strategies (ABS), a JV between HealingMaps and Capstone Management Group, today announced the official launch of the Healing Health Alliance, the first-of-its-kind Group Purchasing Organization (GPO) dedicated...
Multimedia / Internet / Online Services, Publishing / Informational Services, Health, Psychedelics
2025-07-01 9:00 AM EDT | HealingMaps Inc.